David B. Musket - 09 Oct 2023 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Role: Director
Signature: /s/ Linda Marban, Attorney-in-Fact
Issuer symbol: CAPR
Transactions as of: 09 Oct 2023
Net transactions value: +$14,334
Form type: 4
Filing time: 11 Oct 2023, 09:15:08 UTC
Previous filing: 06 Oct 2023
Next filing: 13 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CAPR	Common Stock	Purchase	$14,334	+5,083	+20%	$2.82	31,126	09 Oct 2023	Direct	F1
holding	CAPR	Common Stock						7,096	09 Oct 2023	Held by Reporting Person's IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.85, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.85, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.